← Leaderboards
Thomas Edward Smithgall
University Of Pittsburgh At Pittsburgh
$26,440,514
Attributed
$27,715,512
Total exposure
24
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,715,512 · 24
By mechanism
R01$21,944,143 · 11
R42$1,992,210 · 1
R21$1,611,166 · 5
R41$822,797 · 2
R56$467,658 · 1
N43$306,500 · 1
Top collaborators
- Joanne I Yeh4 shared
- John Jeff Alvarado1 shared
- Paul A. Johnston1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- William E Klunk$26,129,826
- Robert Y. Moore$745,139
- Ari Selzer$167,114
- John Jeff Alvarado$192,500
- Lori A Emert-Sedlak$155,166
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsSmall MoleculeBasePhosphotransferasesProteinsSrc-Family KinasesInhibitor/AntagonistIn VitroMutantProtein Tyrosine KinaseIn VivoComplexSignal TransductionPharmaceutical PreparationsStructureHiv-1Acquired Immunodeficiency SyndromeLaboratoriesMutationAffectPathogenesisResistanceNef ProteinAnti-Retroviral Agents
Grant awards (87)
Chemical Biology of HIV-1 Nef$752,696
R01 · FY2025 · AI · contact PI
Cell-Based HTS Campaign to Identify Negative Allosteric Modulators of the Leukemia-associated Tyrosine Kinase, BTKâ.$652,558
R01 · FY2025 · CA
Alternative Treatment for Syphilis$306,500
N43 · FY2025 · AI · contact PI
Discovery and Development of Allosteric Inhibitors of Src-family Kinases for AML$185,831
R21 · FY2025 · CA · contact PI
Chemical Biology of HIV-1 Nef$752,696
R01 · FY2024 · AI · contact PI
Chemical Biology of HIV-1 Nef$627,513
R01 · FY2023 · AI · contact PI
Precision Targeting of Myeloid Src-family Kinases in Acute Myelogenous Leukemia$426,919
R01 · FY2023 · CA · contact PI
Precision Targeting of Myeloid Src-family Kinases in Acute Myelogenous Leukemia$53,678
R01 · FY2023 · CA · contact PI
Chemical Biology of HIV-1 Nef$627,513
R01 · FY2022 · AI · contact PI
Precision Targeting of Myeloid Src-family Kinases in Acute Myelogenous Leukemia$426,919
R01 · FY2022 · CA · contact PI
Precision Targeting of Myeloid Src-family Kinases in Acute Myelogenous Leukemia$80,516
R01 · FY2022 · CA · contact PI
Chemical Biology of HIV-1 Nef$619,290
R01 · FY2021 · AI · contact PI
Precision Targeting of Myeloid Src-family Kinases in Acute Myelogenous Leukemia$435,632
R01 · FY2021 · CA · contact PI
PROTACS Against Nef as a Functional Cure for HIV Infection$297,797
R41 · FY2021 · AI · contact PI
Precision Targeting of Myeloid Src-family Kinases in Acute Myelogenous Leukemia$80,868
R01 · FY2021 · CA · contact PI
Precision Targeting of Myeloid Src-family Kinases in Acute Myelogenous Leukemia$26,231
R01 · FY2021 · CA · contact PI
Chemical Biology of HIV-1 Nef$617,646
R01 · FY2020 · AI · contact PI
Precision Targeting of Myeloid Src-family Kinases in Acute Myelogenous Leukemia$435,632
R01 · FY2020 · CA · contact PI
PROTACS Against Nef as a Functional Cure for HIV Infection$300,000
R41 · FY2020 · AI · contact PI
Structural Biology of HIV-1 Nef with Host Effectors and Small Molecule Inhibitors$467,658
R56 · FY2019 · AI · contact PI
Precision Targeting of Myeloid Src-family Kinases in Acute Myelogenous Leukemia$435,632
R01 · FY2019 · CA · contact PI
Small Molecule Inhibitors of HIV Nef Signaling$385,000
R01 · FY2019 · AI · contact PI
Lumina S5 Imaging System for Microbiology and Molecular Genetics$287,149
S10 · FY2019 · OD · contact PI
Small Molecule Inhibitors of HIV Nef Signaling$385,000
R01 · FY2018 · AI · contact PI
Small Molecule Inhibitors of HIV1 Nef Virulence Factor for Treatment of HIV_AIDS$991,186
R42 · FY2017 · GM · contact PI
Structural Biology of HIV-1 Nef with Host Effectors and Small Molecule Inhibitors$385,000
R01 · FY2017 · AI · contact PI
Small Molecule Inhibitors of HIV Nef Signaling$385,000
R01 · FY2017 · AI · contact PI
High-throughput Discovery of Chemical Probes for HIV-1 Nef Function$296,450
R01 · FY2017 · GM · contact PI
Small Molecule Inhibitors of HIV1 Nef Virulence Factor for Treatment of HIV_AIDS$1,001,024
R42 · FY2016 · GM · contact PI
Small Molecule Inhibitors of HIV Nef Signaling$385,000
R01 · FY2016 · AI · contact PI
Structural Biology of HIV-1 Nef with Host Effectors and Small Molecule Inhibitors$385,000
R01 · FY2016 · AI · contact PI
High-throughput Discovery of Chemical Probes for HIV-1 Nef Function$296,450
R01 · FY2016 · GM · contact PI
Validation of the Fes Tyrosine Kinase as an Inhibitor Target in Multiple Myeloma$200,970
R21 · FY2016 · CA · contact PI
High-throughput Discovery of Chemical Probes for HIV-1 Nef Function$192,500
R01 · FY2016 · GM · contact PI
Structural Biology of HIV-1 Nef with Host Effectors and Small Molecule Inhibitors$385,000
R01 · FY2015 · AI · contact PI
Small Molecule Inhibitors of HIV Nef Signaling$385,000
R01 · FY2015 · AI · contact PI
High-throughput Discovery of Chemical Probes for HIV-1 Nef Function$296,450
R01 · FY2015 · GM · contact PI
Validation of the Fes Tyrosine Kinase as an Inhibitor Target in Multiple Myeloma$167,475
R21 · FY2015 · CA · contact PI
Structural Biology of HIV-1 Nef with Host Effectors and Small Molecule Inhibitors$384,063
R01 · FY2014 · AI · contact PI
Small Molecule Inhibitors of HIV Nef Signaling$374,963
R01 · FY2014 · AI · contact PI
Small Molecule Inhibitors of HIV1 Nef Virulence Factor for Treatment of HIV_AIDS$225,000
R41 · FY2014 · GM · contact PI
Structural Biology of HIV-1 Nef with Host Effectors and Small Molecule Inhibitors$358,375
R01 · FY2013 · AI · contact PI
Small Molecule Inhibitors of HIV Nef Signaling$352,465
R01 · FY2013 · AI · contact PI
Allosteric Inhibitor Discovery Technology for Protein Kinases$187,379
R21 · FY2013 · CA · contact PI
Small Molecule Inhibitors of HIV Nef Signaling$374,963
R01 · FY2012 · AI · contact PI
A Tumor Suppressor Function for the c-Fes Tyrosine Kinase in Colon Cancer$252,084
R01 · FY2012 · CA · contact PI
Allosteric Inhibitor Discovery Technology for Protein Kinases$165,844
R21 · FY2012 · CA · contact PI
Small Molecule Inhibitors of HIV Nef Signaling$374,963
R01 · FY2011 · AI · contact PI
A Tumor Suppressor Function for the c-Fes Tyrosine Kinase in Colon Cancer$252,122
R01 · FY2011 · CA · contact PI
Small Molecule Inhibitors of HIV Nef Signaling$378,750
R01 · FY2010 · AI · contact PI
A Tumor Suppressor Function for the c-Fes Tyrosine Kinase in Colon Cancer$259,959
R01 · FY2010 · CA · contact PI
Cytoplasmic Tyrosine Kinase Pathways and ES Cell Fate$253,279
R01 · FY2010 · GM · contact PI
Structural Biology of HIV Nef-Src Family Kinase Complexes$227,250
R21 · FY2010 · AI · contact PI
Src Family Kinases as Molecular Targets for HIV/Nef$223,114
R01 · FY2010 · CA · contact PI
A Tumor Suppressor Function for the c-Fes Tyrosine Kinase in Colon Cancer$259,997
R01 · FY2009 · CA · contact PI
Cytoplasmic Tyrosine Kinase Pathways and ES Cell Fate$255,954
R01 · FY2009 · GM · contact PI
Src Family Kinases as Molecular Targets for HIV/Nef$223,186
R01 · FY2009 · CA · contact PI
Structural Biology of HIV Nef-Src Family Kinase Complexes$189,375
R21 · FY2009 · AI · contact PI
A Tumor Suppressor Function for the c-Fes Tyrosine Kinase in Colon Cancer$270,516
R01 · FY2008 · CA · contact PI
Cytoplasmic Tyrosine Kinase Pathways and ES Cell Fate$256,069
R01 · FY2008 · GM · contact PI
Src Family Kinases as Molecular Targets for HIV/Nef$223,256
R01 · FY2008 · CA · contact PI
PROJECT 4$145,022
P50 · FY2008 · GM · contact PI
Cytoplasmic Tyrosine Kinase Pathways and ES Cell Fate$110,279
R01 · FY2008 · GM · contact PI
Targeting HIV-1 Nef with Small Molecules$25,000
R03 · FY2008 · MH · contact PI
Cytoplasmic Tyrosine Kinase Pathways and ES Cell Fate$256,180
R01 · FY2007 · GM · contact PI
Src Family Tyrosine Kinases in Tumor Cell Signaling$226,149
R01 · FY2007 · CA · contact PI
Src Family Kinases as Molecular Targets for HIV/Nef$223,324
R01 · FY2007 · CA · contact PI
PROJECT 4$113,867
P50 · FY2007 · GM · contact PI
Small Molecule Inhibitors of HIV Nef Signaling$357,728
R01 · FY2006 · AI · contact PI
Src Family Tyrosine Kinases in Tumor Cell Signaling$233,023
R01 · FY2006 · CA · contact PI
Src Family Kinases as Molecular Targets for HIV/Nef$230,061
R01 · FY2006 · CA · contact PI
Small Molecule Inhibitors of HIV Nef Signaling$366,480
R01 · FY2005 · AI
Src Family Tyrosine Kinases in Tumor Cell Signaling$238,751
R01 · FY2005 · CA
REGULATION OF P93 C FES TYROSINE KINASE ACTIVITY$218,125
R01 · FY2005 · CA
Small Molecule Inhibitors of HIV Nef Signaling$366,619
R01 · FY2004 · AI
REGULATION OF P93 C FES TYROSINE KINASE ACTIVITY$262,932
R01 · FY2004 · CA
Src Family Tyrosine Kinases in Tumor Cell Signaling$238,868
R01 · FY2004 · CA
REGULATION OF P93 C FES TYROSINE KINASE ACTIVITY$397,436
R01 · FY2003 · CA
Small Molecule Inhibitors of HIV Nef Signaling$183,979
R01 · FY2003 · AI
REGULATION OF P93 C FES TYROSINE KINASE ACTIVITY$352,463
R01 · FY2002 · CA
SRC FAMILY KINASES AS MOLECULAR TARGETS FOR HIV NEF$236,897
R01 · FY2002 · CA
Selective Inhibitors of SRC Family Kinases in Neoplasia$149,542
R21 · FY2002 · CA
REGULATION OF P93 C FES TYROSINE KINASE ACTIVITY$239,661
R01 · FY2001 · CA
SRC FAMILY KINASES AS MOLECULAR TARGETS FOR HIV NEF$229,998
R01 · FY2001 · CA
Selective Inhibitors of SRC Family Kinases in Neoplasia$137,500
R21 · FY2001 · CA
SRC FAMILY KINASES AS MOLECULAR TARGETS FOR HIV NEF$223,299
R01 · FY2000 · CA
REGULATION OF P93C FES PROTEIN TYROSINE KINASE ACTIVITY$210,024
R01 · FY2000 · CA